Juvenile Idiopathic Arthritis (JIA) Clinical Trials

11 recruiting

Juvenile Idiopathic Arthritis (JIA) Trials at a Glance

11 actively recruiting trials for juvenile idiopathic arthritis (jia) are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Çankaya, Calgary, and Columbus. Lead sponsors running juvenile idiopathic arthritis (jia) studies include Hacettepe University, Meyer Children's Hospital IRCCS, and Duke University.

Browse juvenile idiopathic arthritis (jia) trials by phase

Treatments under study

About Juvenile Idiopathic Arthritis (JIA) Clinical Trials

Looking for clinical trials for Juvenile Idiopathic Arthritis (JIA)? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Juvenile Idiopathic Arthritis (JIA) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Juvenile Idiopathic Arthritis (JIA) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 3

OLE Study With Filgotinib in JIA

Juvenile Idiopathic Arthritis (JIA)
Alfasigma S.p.A.80 enrolled4 locationsNCT07553182
Recruiting
Phase 4

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital477 enrolled2 locationsNCT07087912
Recruiting
Phase 3

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University400 enrolled6 locationsNCT06654882
Recruiting
Not Applicable

Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA)
Istanbul University - Cerrahpasa30 enrolled1 locationNCT07234747
Recruiting

Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients

Juvenile Idiopathic Arthritis (JIA)Childhood Rheumatic Diseases
Hacettepe University50 enrolled1 locationNCT07185750
Recruiting

Angiogenic Biomarkers in Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA)
Assistance Publique - Hôpitaux de Paris300 enrolled1 locationNCT05534347
Recruiting

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

SarcoidosisBirdshot ChorioretinitisBehcet Disease+5 more
Oregon Health and Science University125 enrolled1 locationNCT07065747
Recruiting

CAPRI National Juvenile Idiopathic Arthritis Registry

Juvenile Idiopathic Arthritis (JIA)
University of British Columbia1,238 enrolled15 locationsNCT03245801
Recruiting

Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA)
Hacettepe University80 enrolled2 locationsNCT06806774
Recruiting
Not Applicable

Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA)
Meyer Children's Hospital IRCCS20 enrolled1 locationNCT06874608
Recruiting

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

Ulcerative Colitis (UC)Crohn Disease (CD)Juvenile Idiopathic Arthritis (JIA)
Meyer Children's Hospital IRCCS90 enrolled4 locationsNCT06862843